Cytokinetics Announces Initiation of Phase 1 Clinical Study of CK-3772271

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 8/24/2026

1. NVDA
2. JMKE
3. SPY
4. BABA
5. REF
6. XPEV
7. USO
8. TSLA
9. REAX
10. CAPR

Go back to Cytokinetics Announces Initiation of Phase 1 Clinical Study of CK-3772271
CYTOKINETICS (NASDAQ: CYTK) Delayed: 77.09 +0.25 (0.33%)
Previous Close $76.84    52 Week High $13.18 
Open $77.20    52 Week Low $6.00 
Day High $77.99    P/E N/A 
Day Low $75.65    EPS $-1.24 
Volume 1,212,286